Immune checkpoint inhibitor–associated myocarditis: a systematic analysis of case reports

BACKGROUND: Immune checkpoint inhibitors (ICIs) therapy can be complicated by their potential cardiovascular toxicities, including myocarditis. Nowadays, no prospective trials have focused on ICI-associated myocarditis optimized management. Available evidence only come from case reports or series. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Caie, Zhao, Guo, Zhang, Zhen, Yang, Lukui, Liu, Shihao, Li, Guifang, Wang, Hongxia, Huang, Jiaxin, Wang, Shuhang, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590906/
https://www.ncbi.nlm.nih.gov/pubmed/37876928
http://dx.doi.org/10.3389/fimmu.2023.1275254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10590906/
https://www.ncbi.nlm.nih.gov/pubmed/37876928
http://dx.doi.org/10.3389/fimmu.2023.1275254

Ejemplares similares